Evidence map›Paper›PMID 30094353›Full record

ArticleClinical and translational radiation oncology2018

Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic.

Anna Patrikidou, Pierre Maroun, Jean-Jacques Patard, Hervé Baumert, Laurence Albiges, Christophe Massard, Yohann Loriot, Bernard Escudier, Mario Di Palma, Julia Arfi-Rouche and 5 more

Abstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Influence of Geography on Prostate Cancer Treatment.International journal of radiation oncology, biology, physics · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anna PatrikidouGustave Roussy, Université Paris-Saclay, Département de médecine oncologique, F-94800 Villejuif, France.
Pierre MarounGustave Roussy, Université Paris-Saclay, Département de Radiothérapie Oncologique, F-94800 Villejuif, France.
Jean-Jacques PatardHôpital Bicêtre, Service d'Urologie, F-94270 Le Kremlin-Bicêtre, France.
Hervé BaumertHôpital Saint-Joseph, Service d'Urologie, F-75014 Paris, France.
Laurence AlbigesGustave Roussy, Université Paris-Saclay, Département de médecine oncologique, F-94800 Villejuif, France.
Christophe MassardGustave Roussy, Université Paris-Saclay, Département de médecine oncologique, F-94800 Villejuif, France.
Yohann LoriotGustave Roussy, Université Paris-Saclay, Département de médecine oncologique, F-94800 Villejuif, France.
Bernard EscudierGustave Roussy, Université Paris-Saclay, Département de médecine oncologique, F-94800 Villejuif, France.
Mario Di PalmaGustave Roussy, Université Paris-Saclay, Département de médecine oncologique, F-94800 Villejuif, France.
Julia Arfi-RoucheGustave Roussy, Université Paris-Saclay, Département d'imagerie médicale, F-94800 Villejuif, France.
Laurence RocherHôpital Bicêtre, Service de Radiologie, F-94270 Le Kremlin-Bicêtre, France.
Zahira MerabetGustave Roussy, Université Paris-Saclay, Département de biologie et pathologie médicales, F-94800 Villejuif, France.
Alberto BossiGustave Roussy, Université Paris-Saclay, Département de Radiothérapie Oncologique, F-94800 Villejuif, France.
Karim FizaziGustave Roussy, Université Paris-Saclay, Département de médecine oncologique, F-94800 Villejuif, France.
Pierre BlanchardGustave Roussy, Université Paris-Saclay, Département de Radiothérapie Oncologique, F-94800 Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe initial treatment decision for newly diagnosed non-metastatic prostate cancer is complex. Multiple valid approaches exist, without a clear and absolute consensus for every clinical scenario, and therefore specialist opinions may vary. Multidisciplinary consultations focusing on shared decision-making aim to provide an apposite tool for the initial treatment decision. We have evaluated the first two years of activity of the Gustave Roussy Prostate Cancer Multidisciplinary Clinic (PCMC), dedicated to the initial decision-making for non-metastatic prostate cancer.

methodsPCMC consists of two consecutive specialist consultations with a urological surgeon and a radiation oncologist, followed by a dedicated Tumor Board discussion. A study questionnaire was addressed to all PCMC patients via postal mail. Medical notes and questionnaire responses of 195 eligible patients were analyzed.

resultsThe questionnaire response rate was 69% (134 patients). Complete satisfaction rate was high (114 of 118 responders, 97%). Patients were offered new treatment options in 55% of cases, and felt better informed in 98% (122 of 125 responders). The double consultation was considered useful (124 of 129 responders, 96%). Reported feeling of active participation was significantly elevated (117 of 131 responders, 89%), while 46% of patients (57 of 125) modified their decision on the management of their prostate cancer following their PCMC consultation.

conclusionsThe experience of a multidisciplinary consultation in the initial management of non-metastatic prostate cancer renders high patient satisfaction, improves their appreciation of feeling better informed, promotes active participation and shared decision-making and strongly influences their final decision.

Indexed as

MultidisciplinaryProstate cancerRadiotherapyShared decision-makingSurgery

Identifiers

PMID30094353
PMCPMC6072649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.